These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14992663)

  • 1. Race, family interactions, and patient stabilization in schizophrenia.
    Rosenfarb IS; Bellack AS; Aziz N; Kratz KM; Sayers S
    J Abnorm Psychol; 2004 Feb; 113(1):109-15. PubMed ID: 14992663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic alliance and family psychoeducation in the treatment of schizophrenia: an exploratory prospective change process study.
    Smerud PE; Rosenfarb IS
    J Consult Clin Psychol; 2008 Jun; 76(3):505-10. PubMed ID: 18540743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization and depot neuroleptic dosages.
    Weiden P; Schooler NR; Severe JB; Lee JH; Schulz SC
    Psychopharmacol Bull; 1993; 29(2):269-75. PubMed ID: 8290676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
    Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Program-level predictors of antipsychotic medication adherence among parolees.
    Farabee D; Shen H; Sanchez S
    Int J Offender Ther Comp Criminol; 2004 Oct; 48(5):561-71. PubMed ID: 15358931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
    Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia.
    Harris MS; Reilly JL; Keshavan MS; Sweeney JA
    Psychol Med; 2006 Apr; 36(4):485-94. PubMed ID: 16388703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Hong Kong.
    Lee S; Chiu MY; Tsang A; Chui H; Kleinman A
    Soc Sci Med; 2006 Apr; 62(7):1685-96. PubMed ID: 16174547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of oral glucose tolerance test in patient with schizophrenia.
    Margetić B; Aukst-Margetić B; Badanjak A
    Psychiatr Danub; 2005 Jun; 17(1-2):94-6. PubMed ID: 16395850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolonged action neuroleptics and the relationship between physician, patient and family].
    Boudef M
    Sante Ment Que; 1995; 20(1):233-47. PubMed ID: 7578708
    [No Abstract]   [Full Text] [Related]  

  • 20. Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment.
    Kinter ET; Schmeding A; Rudolph I; dosReis S; Bridges JF
    Int J Technol Assess Health Care; 2009 Jan; 25(1):35-41. PubMed ID: 19126249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.